LENACAPAVIR SODIUM
UNII BDT58WJ9WE

Substance Identification & Data

This profile provides standardized clinical and technical data for Lenacapavir Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BDT58WJ9WE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2283356-12-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BDT58WJ9WE
CAS Registry Number
2283356-12-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LENACAPAVIR SODIUM
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
BDT58WJ9WE
The specific atomic composition represented as a molecular structure string.
InChIKey
C39H31ClF10N7O5S2.Na
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
SSXPGMNGIORJAQ-PZNXWHLTSA-M
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
USAN ID
JK-53
Identifier assigned by the United States Adopted Names Council.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(Cn1nc(c2c1C([C@]3([C@@]2(C3)[H])[H])(F)F)C(F)(F)F)(=O)N[C@@H](Cc4cc(cc(c4)F)F)c5c(ccc(n5)C#CC(C)(S(=O)(=O)C)C)-c6ccc(c7c(nn(c67)CC(F)(F)F)[N-]S(=O)(=O)C)Cl.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lenacapavir Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LENACAPAVIR SODIUM

Common Names & Synonyms

LENACAPAVIR SODIUM [USAN]
LENACAPAVIR SODIUM [WHO-DD]
N-((1S)-1-(3-(4-CHLORO-3-(METHANESULFONAMIDO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-(METHANESULFONYL)-3-METHYLBUT-1-YN-1-YL)PYRIDIN-2-YL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-2-((3BS,4AR)-5,5-DIFLUORO-3-(TRIFLUOROMETHYL)-3B,4,4A,5-TETRAHYDRO1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOL-1-YL)ACETAMIDE, SODIUM SALT (1:1)

Brand / Trade Names

SUNLENCA
YEZTUGO

Systematic Nomenclature

1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOLE-1-ACETAMIDE, N-((1S)-1-(3-(4-CHLORO-3-((METHYLSULFONYL)AMINO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-METHYL-3-(METHYLSULFONYL)-1-BUTYN-1-YL)-2-PYRIDINYL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-5,5-DIFLUORO-3B,4,4A,5-TETRAHYDRO-3-(TRIFLUOROMETHYL)-, SODIUM SALT (1:1), (3BS,4AR)-

Technical Codes

GS-6207-02
GS-HIV SODIUM

NDC Products Containing LENACAPAVIR SODIUM

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: